FDA Inspection 1229364 — Royal Canin U.S.A., Inc.

Royal Canin U.S.A., Inc. — FEI 3004256151

The FDA completed an inspection of Royal Canin U.S.A., Inc. on February 8, 2024 in Fremont, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 8, 2024
Fiscal Year
2024
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Fremont, NE (United States)